Cerenome CNSY
NASDAQ CNSY
$1.74 +0.06 (+3.57%)
As of: Oct 21, 2026 · 1:50 PM EDT

Cerenome (CNSY) EV to EBITDA (2016)

Updated

Cerenome's EV to EBITDA was 2642568.14 in Q1 2016.

Analysis

Cerenome (CNSY) EV to EBITDA (2016) Analysis & Trends

On a trailing twelve-month basis, Cerenome's EV to EBITDA was 2642536.12 through Mar 31, 2016.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn
2 Johnson & Johnson 616.11 Bn 534.64 Bn 17.26 Bn
3 AbbVie 501.21 Bn 474.32 Bn 12.70 Bn
4 Merck 367.51 Bn 321.89 Bn 12.21 Bn
5 Novartis Ag 297.95 Bn 261.94 Bn 11.24 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn
7 Amgen 235.88 Bn 191.28 Bn 7.24 Bn
8 Gilead Sciences 190.74 Bn 164.94 Bn 6.22 Bn
9 Pfizer 169.40 Bn 116.05 Bn 10.94 Bn
10 Cerenome 12.00 Mn -35.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 1.72 Mn
API Access

Cerenome EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CNSY&period=max&api_key=YOUR_API_KEY